by s2desi5_ksqtherapeutics | May 20, 2024
Tom brings nearly 25 years of leadership experience in cell & gene therapy, biologics, and vaccines to his role as Chief Technology Officer. His experiences span Manufacturing Sciences, CMC Strategy Development, Internal and External Manufacturing Operations,...
by s2desi5_ksqtherapeutics | May 20, 2024
Grace brings over 20 years of patent law expertise in various biologics modalities, including monoclonal antibodies, antibody drug conjugates, and gene therapies. Prior to joining KSQ, Grace worked at Novartis Institutes for BioMedical Research and was responsible...
by s2desi5_ksqtherapeutics | May 20, 2024
Patty Harris has over 20 years of global clinical development experience across a variety of oncology/hematology indications. Prior to joining KSQ, Patty was Vice President of Clinical Sciences at Cogent Biosciences and at Unum Therapeutics where she led the clinical...
by s2desi5_ksqtherapeutics | May 20, 2024
Elizabeth Twomey-Gansler has served as the Head of Human Resources at KSQ Therapeutics since April 2019. Prior to joining KSQ, Elizabeth worked in executive search focusing on the recruitment of physicians and clinical development professionals for life-science...
by s2desi5_ksqtherapeutics | May 20, 2024
Scott Goldman has spent the past twenty years leading medical and scientific organizations in the civilian and government sectors. Prior to joining KSQ, Scott managed clinical antibody-drug-conjugate drug development programs at Mersana Therapeutics and served as an...
